475 related articles for article (PubMed ID: 21885488)
1. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.
Touma Z; Urowitz MB; Taghavi-Zadeh S; Ibañez D; Gladman DD
Rheumatology (Oxford); 2012 Oct; 51(10):1814-9. PubMed ID: 22718868
[TBL] [Abstract][Full Text] [Related]
3. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity.
Touma Z; Urowitz MB; Fortin PR; Landolt C; Toloza SM; Riddell C; Chandran V; Eder L; Ghanem A; Ziouzina O; Taghavi-Zadeh S; Ibañez D; Gladman DD
J Rheumatol; 2011 May; 38(5):868-73. PubMed ID: 21324961
[TBL] [Abstract][Full Text] [Related]
5. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
[TBL] [Abstract][Full Text] [Related]
6. SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years.
Touma Z; Gladman DD; Ibañez D; Urowitz MB
Lupus; 2012 Oct; 21(12):1305-11. PubMed ID: 22800940
[TBL] [Abstract][Full Text] [Related]
7. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
8. Systemic Lupus Erythematosus (SLE) Responder Index response is associated with global benefit for patients with SLE.
Furie R; Wang L; Illei G; Drappa J
Lupus; 2018 May; 27(6):955-962. PubMed ID: 29460699
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Kalunian KC; Urowitz MB; Isenberg D; Merrill JT; Petri M; Furie RA; Morgan-Cox MA; Taha R; Watts S; Silk M; Linnik MD
Rheumatology (Oxford); 2018 Jan; 57(1):125-133. PubMed ID: 29045736
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132.
Burge DJ; Werth VP; Boackle SA; Posada J
Lupus Sci Med; 2024 Feb; 11(1):. PubMed ID: 38325898
[TBL] [Abstract][Full Text] [Related]
11. Novel evidence-based systemic lupus erythematosus responder index.
Furie RA; Petri MA; Wallace DJ; Ginzler EM; Merrill JT; Stohl W; Chatham WW; Strand V; Weinstein A; Chevrier MR; Zhong ZJ; Freimuth WW
Arthritis Rheum; 2009 Sep; 61(9):1143-51. PubMed ID: 19714615
[TBL] [Abstract][Full Text] [Related]
12. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
13. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
Devilliers H; Bonithon-Kopp C; Jolly M
Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
[TBL] [Abstract][Full Text] [Related]
14. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
[TBL] [Abstract][Full Text] [Related]
15. Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.
Parodis I; Emamikia S; Gomez A; Gunnarsson I; van Vollenhoven RF; Chatzidionysiou K
Expert Opin Biol Ther; 2019 Feb; 19(2):157-168. PubMed ID: 30571926
[No Abstract] [Full Text] [Related]
16. Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally.
Yee CS; Gordon C; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards CJ; D'Cruz D; Khamashta MA; Farewell VT
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1623-1630. PubMed ID: 33787088
[TBL] [Abstract][Full Text] [Related]
17. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
Fatemi A; Raeisi A; Sayedbonakdar Z; Smiley A
Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
[TBL] [Abstract][Full Text] [Related]
19. Identifying a Response for the Systemic Lupus Erythematosus Disease Activity 2000 Glucocorticoid Index.
Touma Z; Gladman DD; Zandy M; Su J; Anderson N; Urowitz MB
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1243-1249. PubMed ID: 32433815
[TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.
Touma Z; Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2011 Feb; 38(2):275-84. PubMed ID: 21123323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
